Neurogen announced it has entered into agreements to monetize some of its non-core assets including certain research facilities and its chemical library.
Included within this group of non-core assets were:
- 4 of its 5 buildings for $6M ~($1.3M net cash to Neurogen)
- chemical library for $3M
I try and not use cliches if at all possible but I’ll make an exception for Neurogen; desperate times call for… well, you know the rest.
Neurogen Corporation Announces Agreements for Sale of Non-Core Assets for Combined $9 Million
-(Via Business Wire Health News.)
Theoretically Related Posts
This post was constructed by .
Eben is a highly caffeinated business development associate at a small, cash sensitive pharmaceutical company somewhere in Massachusetts. He enjoys cliche-less banter, compartmentalization, non-equilibrium thermodynamics and NPV analysis. Agree or disagree with what he's posted? He encourages comments.
If one were so inclined, one could follow him at any of these fine web 2.0 establishments:
Feel free to leave a comment below. Eben loves comments. You may also subscribe to comments through this RSS Comments feed or trackback here.
Eben is a highly caffeinated business development associate at a small, cash sensitive pharmaceutical company somewhere in Massachusetts. He enjoys cliche-less banter, compartmentalization, non-equilibrium thermodynamics and NPV analysis. Agree or disagree with what he's posted? He encourages comments.
If one were so inclined, one could follow him at any of these fine web 2.0 establishments:
Feel free to leave a comment below. Eben loves comments. You may also subscribe to comments through this RSS Comments feed or trackback here.
Add New Comment
Thanks. Your comment is awaiting approval by a moderator.
Do you already have an account? Log in and claim this comment.
Add New Comment
Trackbacks
(Trackback URL)